<DOC>
	<DOCNO>NCT02957643</DOCNO>
	<brief_summary>The purpose study investigate effectiveness iron treatment iron deficiency pregnant 2nd 3rd quarter . Every 30 day investigator measure hemoglobin , hematocrit iron serum assess course treatment .</brief_summary>
	<brief_title>Substitution Normal Levels Iron Hemoglobin Pregnant Women With Iron Supplement</brief_title>
	<detailed_description />
	<mesh_term>Iron</mesh_term>
	<criteria>1 . Age equal 18 year 2 . Registration consent 3 . Have complete 12h week pregnancy 4 . Hemoglobin level &lt; 10,5 ptl 5 . Hematocrit &lt; 32 % 1 . Age &lt; 18 year 2 . Absent registration consent 3 . Step pregnancy less 12 week 4 . Coadministration formulation iron oral parenterally 5 . Background liver kirrosis 6 . Background aimosidirosis 7 . Background acquire chronic aimatochromatosis 8 . Aplastic , Hemolytic anemia chronic diseases 9 . Chronic pancreatitis 10 . Subjective renal or/and liver disease 11 . Hypothyroidism yperthyreoeidismos</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>